Ghent-based clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and immune-oncology
MRM Health has raised €55M across 1 funding round from 8 investors, most recently a Series B round in Sep 2025. Based in Ghent, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-04 | Series B | €55M |
| Ackermans & van Haaren (AvH),ATHOS CAPITAL,Biocodex,BNP Paribas Fortis Private Equity,OMX Europe Venture Fund (OMX),Qbic II+2 more |
| View deal → |
